Cargando…

Carvedilol in the Treatment of Portal Hypertension

Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a first line...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Ghamdi, Hamdan
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099066/
https://www.ncbi.nlm.nih.gov/pubmed/21372358
http://dx.doi.org/10.4103/1319-3767.77251
_version_ 1782204028425338880
author Al-Ghamdi, Hamdan
author_facet Al-Ghamdi, Hamdan
author_sort Al-Ghamdi, Hamdan
collection PubMed
description Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a first line option if cirrhotic patients cannot tolerate β-blockers. Despite adequate β-blockade, some patients may still present with variceal bleeding. The effect of carvedilol, a non-selective β and α-1 receptor-blocker, on lowering portal pressure has been investigated in several clinical trials and found to be superior to propranolol in both acute and chronic hemodynamic studies. Recently, carvedilol has also been compared with band ligation for primary prophylaxis against variceal bleeding with equivalent results to band ligation. Patient tolerance to carvedilol in advanced liver disease remains a source of concern. This review examines the place of carvedilol as an alternative to the currently recommended pharmacological therapy in prophylaxis against variceal bleeding.
format Text
id pubmed-3099066
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30990662011-05-23 Carvedilol in the Treatment of Portal Hypertension Al-Ghamdi, Hamdan Saudi J Gastroenterol New Horizon Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a first line option if cirrhotic patients cannot tolerate β-blockers. Despite adequate β-blockade, some patients may still present with variceal bleeding. The effect of carvedilol, a non-selective β and α-1 receptor-blocker, on lowering portal pressure has been investigated in several clinical trials and found to be superior to propranolol in both acute and chronic hemodynamic studies. Recently, carvedilol has also been compared with band ligation for primary prophylaxis against variceal bleeding with equivalent results to band ligation. Patient tolerance to carvedilol in advanced liver disease remains a source of concern. This review examines the place of carvedilol as an alternative to the currently recommended pharmacological therapy in prophylaxis against variceal bleeding. Medknow Publications 2011 /pmc/articles/PMC3099066/ /pubmed/21372358 http://dx.doi.org/10.4103/1319-3767.77251 Text en © Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle New Horizon
Al-Ghamdi, Hamdan
Carvedilol in the Treatment of Portal Hypertension
title Carvedilol in the Treatment of Portal Hypertension
title_full Carvedilol in the Treatment of Portal Hypertension
title_fullStr Carvedilol in the Treatment of Portal Hypertension
title_full_unstemmed Carvedilol in the Treatment of Portal Hypertension
title_short Carvedilol in the Treatment of Portal Hypertension
title_sort carvedilol in the treatment of portal hypertension
topic New Horizon
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099066/
https://www.ncbi.nlm.nih.gov/pubmed/21372358
http://dx.doi.org/10.4103/1319-3767.77251
work_keys_str_mv AT alghamdihamdan carvedilolinthetreatmentofportalhypertension